Zenotech Laboratories Limited (532039) - Financial and Strategic SWOT Analysis Review

Date: July 3, 2013
Pages: 33
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ZD4A064F0E2EN
Leaflet:

Download PDF Leaflet

Zenotech Laboratories Limited (532039) - Financial and Strategic SWOT Analysis Review
Zenotech Laboratories Limited (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

THE PROFILE CONTAINS CRITICAL COMPANY INFORMATION INCLUDING:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

HIGHLIGHTS

Zenotech Laboratories Limited (Zenotech), develops and manufactures generic biopharmaceuticals. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological and generic chemicals. Its product portfolio includes G-CSF, G-MCSF, IL-2 and generic chemical oncology injectables. The company is also developing new biological entities in cancer and neurology areas along with providing contract manufacturing services. Its contract manufacturing services include, generating and characterizing recombinant proteins.

Zenotech Laboratories Limited Key Recent Developments

Feb 08, 2013: Zenotech Labs Reports Revenue Of INR13.8m In Q3 Fiscal 2013
Dec 01, 2012: Zenotech Labs Reports Revenue Of INR7.9m In H1 Fiscal 2013
Nov 14, 2012: Zenotech Labs Reports Revenue Of INR17.4m In Fiscal 2012

KEY BENEFITS OF BUYING THIS PROFILE INCLUDE:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Zenotech Laboratories Limited - Key Facts
Zenotech Laboratories Limited - Key Employees
Zenotech Laboratories Limited - Key Employee Biographies
Zenotech Laboratories Limited - Major Products and Services
Zenotech Laboratories Limited - Pharmaceutical Pipeline Products Data
Zenotech Laboratories Limited, Pipeline Products by Therapy Area
Zenotech Laboratories Limited, Pipeline Products by Development Phase
Zenotech Laboratories Limited - History
Zenotech Laboratories Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Zenotech Laboratories Limited - Key Manufacturing Facilities
Affiliate

SECTION 2 – COMPANY ANALYSIS

Zenotech Laboratories Limited - Business Description
Zenotech Laboratories Limited - SWOT Analysis
SWOT Analysis - Overview
Zenotech Laboratories Limited - Strengths
Strength - Wide Offerings
Strength - Expertise In-house Research Activities
Zenotech Laboratories Limited - Weaknesses
Weakness - Low Liquidity
Zenotech Laboratories Limited - Opportunities
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Changing Demographics
Opportunity - Growth Prospects: Indian Pharmaceutical Market
Zenotech Laboratories Limited - Threats
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Zenotech Laboratories Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zenotech Laboratories Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Zenotech Laboratories Limited, Recent Developments
Feb 08, 2013: Zenotech Labs Reports Revenue Of INR13.8m In Q3 Fiscal 2013
Dec 01, 2012: Zenotech Labs Reports Revenue Of INR7.9m In H1 Fiscal 2013
Nov 14, 2012: Zenotech Labs Reports Revenue Of INR17.4m In Fiscal 2012

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Zenotech Laboratories Limited, Key Facts
Zenotech Laboratories Limited, Key Employees
Zenotech Laboratories Limited, Key Employee Biographies
Zenotech Laboratories Limited, Major Products and Services
Zenotech Laboratories Limited, Number of Pipeline Products by Therapy Area
Zenotech Laboratories Limited, Number of Pipeline Products by Development Stage
Zenotech Laboratories Limited, Pipeline Products By Therapy Area and Development Phase
Zenotech Laboratories Limited, History
Zenotech Laboratories Limited, Other Locations
Zenotech Laboratories Limited, Subsidiaries
Zenotech Laboratories Limited, Key Manufacturing Facilities
Zenotech Laboratories Limited, Affiliate
Zenotech Laboratories Limited, Key Competitors
Zenotech Laboratories Limited, Ratios based on current share price
Zenotech Laboratories Limited, Annual Ratios
Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zenotech Laboratories Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Zenotech Laboratories Limited, Pipeline Products by Therapy Area
Zenotech Laboratories Limited, Pipeline Products by Development Phase
Zenotech Laboratories Limited, Performance Chart (2007 - 2011)
Zenotech Laboratories Limited, Ratio Charts
Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zenotech Laboratories Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Ask Your Question

Zenotech Laboratories Limited (532039) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: